Axsome to Present New Sunosi Data at SLEEP 2023 : vimarsana.

Axsome Therapeutics Inc will present new data on Sunosi (solriamfetol) at SLEEP 2023, including results from the SHARP study.

Related Keywords

United Kingdom , Germany , German , Russell Rosenberg , Hans Van Dongen , Johannes Gutenberg , Department Of Neurology , Axsome Therapeutics Inc , Neurotrials Research , Professor At Washington State University , Medicine Center , Washington State University , Drug Administration , Cognitive Health , Apnea Participants During , Randomized Placebo Controlled , Obstructive Sleep Apnea , Excessive Daytime , Washington State , Board Number , Follow Up Experience , Yaroslav Winter , Mainz Comprehensive Epilepsy , Sleep Medicine Center , Johannes Gutenberg University , Excessive Sleepiness , Effect Sizes , Numbers Needed , Healthcare Resource Utilization Burden , Excessive Daytime Sleepiness , Gregory Parks ,